Maverick Capital’s Caribou Biosciences CRBU Stock Holding History

Maverick Capital’s Portfolio CRBU Stock Details CRBU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.15M	Hold	652,542	–	–	0.01%	105
2026 Q1	$1.24M	Hold	652,542	–	–	0.01%	120
2025 Q4	$1.04M	Hold	652,542	–	–	0.01%	161
2025 Q3	$1.52M	Hold	652,542	–	–	0.02%	181
2025 Q2	$822K	Hold	652,542	–	–	0.01%	184
2025 Q1	$596K	Hold	652,542	–	–	0.01%	198
2024 Q4	$1.04M	Hold	652,542	–	–	0.02%	126
2024 Q3	$1.28M	Hold	652,542	–	–	0.02%	181
2024 Q2	$1.07M	Hold	652,542	–	–	0.02%	209
2024 Q1	$3.35M	Hold	652,542	–	–	0.06%	70
2023 Q4	$3.74M	Hold	652,542	–	–	0.08%	60
2023 Q3	$3.12M	Hold	652,542	–	–	0.07%	55
2023 Q2	$2.77M	Hold	652,542	–	–	0.06%	87
2023 Q1	$3.46M	Hold	652,542	–	–	0.09%	59
2022 Q4	$4.1M	Hold	652,542	–	–	0.1%	63
2022 Q3	$6.88M	Hold	652,542	–	–	0.16%	55
2022 Q2	$3.54M	Hold	652,542	–	–	0.09%	75
2022 Q1	$5.99M	Hold	652,542	–	–	0.11%	71
2021 Q4	$9.75M	Sell	652,542 -300,000	-31%	-$5.83M	0.11%	74
2021 Q3	$21.8M	Buy	+952,542	New	+$23.3M	0.22%	64

Other funds holding CRBU

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Pfizer New York $170M AUM 191.09% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Mackenzie Financial Toronto Ontario, Ontario, Canada $100B AUM 36.93% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

KCM

Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Maverick Capital's CRBU Position: Q2 2026 in Review

Maverick Capital held its Caribou Biosciences (CRBU) position steady in Q2 2026 at 652,542 shares worth $1.15M. The position accounts for 0.01% of the portfolio, ranked #105.

Maverick Capital first reported a position in CRBU in Q3 2021 and has held it in 20 quarters since. The position peaked at $21.8M in Q3 2021. 137 funds tracked by Wall St. Rank hold CRBU as of Q2 2026.

Maverick Capital held 652,542 shares of Caribou Biosciences worth $1.15M as of Q2 2026.
Maverick Capital left its Caribou Biosciences share count unchanged in Q2 2026.
Caribou Biosciences made up 0.01% of Maverick Capital's portfolio in Q2 2026, its #105 holding.
Maverick Capital first reported a position in Caribou Biosciences in Q3 2021 and has held it in 20 quarters since.
Maverick Capital's Caribou Biosciences position peaked at $21.8M in Q3 2021.
137 funds tracked by Wall St. Rank held Caribou Biosciences as of Q2 2026.

Based on Maverick Capital's 13F filing for Q2 2026, filed 14 Aug 2026.